Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 801,695 | 792,739 | 942,261 | 1,442,232 | 1,640,151 |
| Depreciation Amortization | 1,885,296 | 1,896,158 | 1,936,899 | 1,920,971 | 2,040,032 |
| Income taxes - deferred | -78,638 | -132,202 | -43,694 | 79,574 | 126,914 |
| Accounts receivable | -79,510 | -164,341 | -49,184 | -193,078 | 81,897 |
| Accounts payable and accrued liabilities | -49,993 | -11,803 | -9,194 | 23,302 | -18,632 |
| Other Working Capital | 480,791 | 607,469 | -134,931 | -115,669 | 1,411,269 |
| Other Operating Activity | -377,596 | -142,870 | -358,606 | -212,007 | -446,097 |
| Operating Cash Flow | $2,582,046 | $2,845,151 | $2,283,551 | $2,945,325 | $4,835,534 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -741,514 | -723,472 | -724,648 | -981,897 | -1,183,885 |
| Net Acquisitions | 656,492 | 148,274 | 1,083 | -451,621 | -279,152 |
| Purchase Of Investment | -88,192 | -110,788 | -111,303 | -152,716 | -110,119 |
| Sale Of Investment | 81,303 | 96,969 | 60,762 | 170,977 | 48,252 |
| Investing Cash Flow | $-91,913 | $-589,017 | $-774,106 | $-1,415,257 | $-1,524,904 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 91,775 | 70,714 | 755,530 | 2,134,557 | 907,931 |
| Debt Issued | 66,563 | 452,268 | 1,039,821 | 1,471,888 | 2,422,710 |
| Debt Repayment | -902,971 | -758,328 | -784,532 | -2,464,397 | -1,811,937 |
| Common Stock Issued | N/A | N/A | 21,233 | 7,703 | 14,454 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -418,068 |
| Dividend Paid | -717,273 | -694,824 | -740,652 | -860,468 | -819,540 |
| Other Financing Activity | -1,318,334 | -1,081,317 | -1,995,452 | -1,501,230 | -3,338,668 |
| Financing Cash Flow | $-2,780,240 | $-2,011,486 | $-1,704,051 | $-1,211,946 | $-3,043,118 |
| Exchange Rate Effect | 28,349 | -78,583 | -24,404 | 155,256 | -183,192 |
| Beginning Cash Position | 1,544,400 | 1,378,620 | 1,561,072 | 1,279,569 | 1,151,122 |
| End Cash Position | 1,282,643 | 1,544,686 | 1,342,062 | 1,752,946 | 1,235,442 |
| Net Cash Flow | $-261,757 | $166,066 | $-219,010 | $473,377 | $84,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,582,046 | 2,845,151 | 2,283,551 | 2,945,325 | 4,835,534 |
| Capital Expenditure | -756,775 | -740,938 | -762,794 | -1,010,793 | -1,201,680 |
| Free Cash Flow | 1,825,271 | 2,104,213 | 1,520,757 | 1,934,532 | 3,633,854 |